MedTrace Logo

A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants

NCT05539976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-12-01

No results posted yet for this study

Summary

The purpose of this study is to develop taste profiles of iberdomide and mezigdomide drug substances and oral formulation prototypes in order to develop a pediatric oral form of iberdomide and mezigdomide.

Conditions

  • Healthy Participants

Sponsors & Collaborators

Principal Investigators

  • Bristol Myers Squibb · Bristol-Myers Squibb

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2022-11-14
Completion
2022-11-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05539976 on ClinicalTrials.gov